Drug supply answer supplier on Wednesday mentioned it’s planning to get listed on the National Stock Exchange of India (NSE) on November 25. ZIM Laboratories, already listed on the BSE since June 2018, will now prolong its itemizing to the NSE, the corporate mentioned in an announcement.
As of date, the corporate mentioned, it has offered over 85 per cent return to its traders from the itemizing value.
Based on the September 2022 shareholding sample out there with the BSE, the corporate’s promoters personal a 33.26 per cent stake within the agency, of which, Dr Anwar Daud, Chairman and Managing Director, holds a 27.37 per cent stake and Mathew Cyriac, Govt Chairman, Florintree Advisors, as an investor owns 21.86 per cent.
ZIM Laboratories is a pharmaceutical firm, centered on offering progressive drug supply options that present affected person comfort and adherence to drug therapy.
